Health
Long-acting injectable antipsychotics provide better outcomes in bipolar disorder and older schizophrenia patients
A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has found that long-acting injectable (LAI) antipsychotics provide better treatment outcomes than oral…
AI Summary
A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, University of Hong Kong, found that long‑acting injectable antipsychotics yield better treatment outcomes than oral antipsychotic medications for patients 65 years and older with schizophrenia. The study compared the two medication routes in this older population and reported superior results for the injectable formulation.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Nursing home beds are becoming more scarceContinue reading
- New polymer could enable gastrointestinal transit monitoring without ionizing radiationContinue reading
- Landmark trial evaluates chemotherapy benefit in high-risk early-stage breast cancerContinue reading
- President Trump's FDA commissioner nom, Dr. Heidi Overton, faces Senators' questionsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow